Logo QuidelOrtho

QuidelOrtho (QDEL) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
QuidelOrtho · Health Care · ref. ETF XLV · 44 calls · price $14.1
💬JPI AI AssistantTry it →
What the company does: QuidelOrtho Corporation provides diagnostic testing solutions.

📈 QuidelOrtho (QDEL) stock price

$14.1-46.1% over range
Oct 14, 25low $9.96 · high $35.38Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 3 analysts
📊 JPI status : QuidelOrtho has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 QDEL price target & analyst consensus — price $14.10

The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$18+27.7%
Median target · of 3 targets$12.5-11.3%
Lowest target · 1 firm of 3$12-14.9%
Current price$14.1
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold267%
Sell133%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about QuidelOrtho? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on QDEL

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
JP Morgan ↗ 100% +29.7% 2
UBS ↗ 100% +14.5% 2
Raymond James ↗ 0% -35.7% 4
RBC Capital ↗ 0% -36.5% 11
Citigroup ↗ 0% -37.0% 3

📊 What $1,000 invested in QuidelOrtho would be worth › open the full page

In short — $1,000 invested in QuidelOrtho 10 years ago would be worth $833 today, i.e. -2%/yr on average. Best year: 2020 (+139%), worst: 2024 (-40%). Price performance, excluding dividends.

If I'd invested $1,000 in QuidelOrtho

InvestmentWorth todayGain
1 years ago$396-60%
3 years ago$206-79%
5 years ago$98.30-90%
→ See QuidelOrtho's full return history + gain calculator

Return by year (QuidelOrtho)

YearReturn$1,000 invested at year start
2026 (YTD)-38%$618 (-38%)
2025-36%$396 (-60%)
2024-40%$240 (-76%)
→ See QuidelOrtho's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on QuidelOrtho

Loading news…

📋 All analyst calls on QDEL

Citigroup ↗
Jul 8, 26
■ Neutral neutral · not a buy · 🎯$18
Price at call : $17.44 — gap to target +3%
Today : $14.1 — gap to target +28%
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jul 8, 27
JP Morgan ↗
Jul 1, 26
▼ Underweight · 🎯$12
Price at call : $18.25 — upside -34%
Today : $14.1 — upside -15%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Jul 1, 27
Jefferies ↗
May 7, 26
■ Hold neutral · not a buy · 🎯$12.5
Price at call : $10.77 — gap to target +16%
Today : $14.1 — gap to target -11%
🎯 on QDEL : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : May 7, 27
Citigroup ↗
May 6, 26
■ Neutral neutral · not a buy · 🎯$13
Price at call : $10.77 — gap to target +21%
Today : $14.1 — gap to target -8%
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : May 6, 27
UBS ↗
Apr 10, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.08 — gap to target +6%
Today : $14.1 — gap to target +21%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Apr 10, 27
Citigroup ↗
Feb 12, 26
■ Neutral neutral · not a buy · 🎯$30
Price at call : $23.58 — gap to target +27%
Today : $14.1 — gap to target +113%
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Feb 12, 27
UBS ↗
Jan 21, 26
■ Neutral neutral · not a buy · 🎯$35
Price at call : $29.42 — gap to target +19%
Today : $14.1 — gap to target +148%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jan 21, 27
JP Morgan ↗
Nov 7, 25
▼ Underweight · 🎯$22
Price at call : $19.73 — upside +12%
Today : $14.1 — upside +56%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Nov 7, 26
See the other 36 calls, newest to oldest
UBS ↗
Nov 6, 25
■ Neutral neutral · not a buy · 🎯$31
Price at call : $20.35 — gap to target +52%
Today : $14.1 — gap to target +120%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Nov 6, 26
Citigroup ↗
Oct 7, 25
■ Neutral neutral · not a buy · 🎯$33
Price at call : $27.71 — gap to target +19%
Today : $14.1 — gap to target +134%
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Oct 7, 26
UBS ↗
Aug 7, 25
■ Neutral neutral · not a buy · 🎯$26
Price at call : $23.91 — gap to target +9%
Today : $14.1 — gap to target +84%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Aug 7, 26
Citigroup ↗
Aug 6, 25
▲ Buy · 🎯$40
Price at call : $24.4 — upside +64%
Today : $14.1 — upside +184%
Expected +64% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
-49.6%
stock -50% · XLV +28%
matured Aug 6, 26
UBS ↗
May 8, 25
■ Neutral neutral · not a buy · 🎯$29
Price at call : $36.34 — gap to target -20%
Today : $14.1 — gap to target +106%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 8, 26
Jefferies ↗
May 8, 25
▲ Buy · 🎯$44
Price at call : $36.34 — upside +21%
Today : $14.1 — upside +212%
Expected +21% · Actual -73% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
-72.6%
stock -73% · XLV +8%
matured May 8, 26
JP Morgan ↗
Apr 21, 25
▼ Underweight · 🎯$25
Price at call : $24.46 — upside +2%
Today : $14.1 — upside +77%
Expected +2% · Actual -51% · Reason (≤ −15%) : ✓ Yes
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
+51.3%
stock -51% · XLV +8%
matured Apr 21, 26
RBC Capital ↗
Feb 13, 25
▲ Outperform · 🎯$61
Price at call : $40.57 — upside +50%
Today : $14.1 — upside +333%
Expected +50% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-43.0%
stock -43% · XLV +9%
matured Feb 13, 26
UBS ↗
Feb 13, 25
■ Neutral neutral · not a buy · 🎯$45
Price at call : $40.57 — gap to target +11%
Today : $14.1 — gap to target +219%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Feb 13, 26
Citigroup ↗
Dec 11, 24
▲ Buy · 🎯$50
Price at call : $41.52 — upside +20%
Today : $14.1 — upside +255%
Expected +20% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
-28.6%
stock -29% · XLV +8%
matured Dec 11, 25
Jefferies ↗
Dec 10, 24
■ Hold neutral · not a buy · 🎯$43
Price at call : $38.5 — gap to target +12%
Today : $14.1 — gap to target +205%
🎯 on QDEL : 0% (1 call matured) · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Dec 10, 25
RBC Capital ↗
Aug 16, 24
▲ Outperform · 🎯$61
Price at call : $44.95 — upside +36%
Today : $14.1 — upside +333%
Expected +36% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-42.6%
stock -43% · XLV -12%
matured Aug 16, 25
RBC Capital ↗
Aug 1, 24
▲ Outperform · 🎯$61
Price at call : $42.01 — upside +45%
Today : $14.1 — upside +333%
Expected +45% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-42.6%
stock -43% · XLV -12%
matured Aug 1, 25
RBC Capital ↗
May 9, 24
▲ Outperform · 🎯$68
Price at call : $42.61 — upside +60%
Today : $14.1 — upside +382%
Expected +60% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-12.2%
stock -12% · XLV -5%
matured May 9, 25
UBS ↗
Mar 4, 24
▼ Sell · 🎯$42
Price at call : $44.33 — upside -5%
Today : $14.1 — upside +198%
Expected -5% · Actual -12% · Reason (≤ −15%) : ✗ No
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+12.1%
stock -12% · XLV +1%
matured Mar 4, 25
Craig-Hallum ↗
Feb 14, 24
■ Hold neutral · not a buy
🎯 on QDEL : no call matured yet · 📊 on Health : 52% · +14.5% (25 calls)
in progress (365j)
matures : Feb 13, 25
RBC Capital ↗
Feb 14, 24
▲ Outperform · 🎯$81
Price at call : $43.98 — upside +84%
Today : $14.1 — upside +474%
Expected +84% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-7.8%
stock -8% · XLV -0%
matured Feb 13, 25
Raymond James ↗
Feb 14, 24
▲ Outperform · 🎯$76
Price at call : $45.27 — upside +68%
Today : $14.1 — upside +439%
Expected +68% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (4 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-8.0%
stock -8% · XLV +2%
matured Feb 13, 25
William Blair ↗
Feb 14, 24
■ Market Perform neutral · not a buy
🎯 on QDEL : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Feb 13, 25
JP Morgan ↗
Feb 14, 24
▼ Underweight · 🎯$37
Price at call : $45.27 — upside -18%
Today : $14.1 — upside +162%
Expected -18% · Actual -8% · Reason (≤ −15%) : ✗ No
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
+8.0%
stock -8% · XLV +2%
matured Feb 13, 25
RBC Capital ↗
Dec 21, 23
▲ Outperform · 🎯$130
Price at call : $73.98 — upside +76%
Today : $14.1 — upside +822%
Expected +76% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-39.6%
stock -40% · XLV +3%
matured Dec 20, 24
Citigroup ↗
Dec 11, 23
■ Neutral neutral · not a buy · 🎯$72
Price at call : $65.77 — gap to target +9%
Today : $14.1 — gap to target +411%
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Dec 10, 24
Raymond James ↗
Nov 2, 23
▲ Strong Buy · 🎯$100
Price at call : $64.27 — upside +56%
Today : $14.1 — upside +609%
Expected +56% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (4 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-39.2%
stock -39% · XLV +15%
matured Nov 1, 24
RBC Capital ↗
Sep 19, 23
▲ Outperform · 🎯$140
Price at call : $75.78 — upside +85%
Today : $14.1 — upside +893%
Expected +85% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-39.0%
stock -39% · XLV +18%
matured Sep 18, 24
Raymond James ↗
Aug 15, 23
▲ Strong Buy · 🎯$110
Price at call : $74.7 — upside +47%
Today : $14.1 — upside +680%
Expected +47% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (4 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-41.7%
stock -42% · XLV +12%
matured Aug 14, 24
JP Morgan ↗
Aug 9, 23
■ Neutral neutral · not a buy · 🎯$85
Price at call : $77.39 — gap to target +10%
Today : $14.1 — gap to target +503%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Aug 8, 24
RBC Capital ↗
Aug 9, 23
▲ Outperform · 🎯$136
Price at call : $77.39 — upside +76%
Today : $14.1 — upside +865%
Expected +76% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-46.2%
stock -46% · XLV +11%
matured Aug 8, 24
RBC Capital ↗
May 4, 23
▲ Outperform · 🎯$133
Price at call : $88.61 — upside +50%
Today : $14.1 — upside +843%
Expected +50% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-51.0%
stock -51% · XLV +6%
matured May 3, 24
RBC Capital ↗
Feb 16, 23
▲ Outperform · 🎯$136
Price at call : $91.39 — upside +49%
Today : $14.1 — upside +865%
Expected +49% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-49.0%
stock -49% · XLV +10%
matured Feb 16, 24
Raymond James ↗
Feb 16, 23
▲ Strong Buy · 🎯$130
Price at call : $90.68 — upside +43%
Today : $14.1 — upside +822%
Expected +43% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (4 calls matureds) · 📊 on Health : 39.7% · -2.1% (219 calls)
-53.9%
stock -54% · XLV +11%
matured Feb 16, 24
Citigroup ↗
Dec 12, 22
▲ Buy · 🎯$125
Price at call : $97.5 — upside +28%
Today : $14.1 — upside +787%
Expected +28% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
-32.8%
stock -33% · XLV -4%
matured Dec 12, 23
RBC Capital ↗
Dec 7, 22
▲ Outperform · 🎯$125
Price at call : $92.61 — upside +35%
Today : $14.1 — upside +787%
Expected +35% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on QDEL : 0% (11 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-28.0%
stock -28% · XLV -5%
matured Dec 7, 23
JP Morgan ↗
Nov 3, 22
■ Neutral neutral · not a buy · 🎯$93
Price at call : $90.81 — gap to target +2%
Today : $14.1 — gap to target +560%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Nov 3, 23
UBS ↗
Oct 14, 22
■ Neutral neutral · not a buy · 🎯$86
Price at call : $76.29 — gap to target +13%
Today : $14.1 — gap to target +510%
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Oct 14, 23
Citigroup ↗
Sep 19, 22
■ Neutral neutral · not a buy · 🎯$90
Price at call : $79.15 — gap to target +14%
Today : $14.1 — gap to target +538%
🎯 on QDEL : 0% (3 calls matureds) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Sep 19, 23
UBS ↗
Jul 20, 22
▼ Sell · 🎯$86
Price at call : $104.72 — upside -18%
Today : $14.1 — upside +510%
Expected -18% · Actual -17% · Reason (≤ −15%) : ✓ Yes
🎯 on QDEL : 100% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+16.9%
stock -17% · XLV +5%
matured Jul 20, 23

Frequently asked questions

Should I buy QuidelOrtho stock?

This isn't buy advice. For QuidelOrtho, the analyst consensus is "Hold", with an average price target of $12.50 (-11% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on QuidelOrtho). We show the numbers — you decide.

Is it too late to buy QuidelOrtho? How high can it go?

The most bullish analyst target on QuidelOrtho is $18.00 (+28% above today's price); the average is $12.50. That's the upside they see. Check how reliable those analysts have actually been on QuidelOrtho on our site before trusting it.

Is QuidelOrtho still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 5 analysts have a real record on QuidelOrtho, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

Will QuidelOrtho stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will QDEL stock recover (go back up)?

What has QuidelOrtho's past performance been?

Historical returns and a "how much if I had invested" calculator: QDEL performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)